MRNA
Underperforming stock considering market fall and participation of the fall.
Relatively Under performer.
testing 78.6% retracement looks to be on charts.
114-100 key support levels to stall the fall.
If recovery happen at the support good.
RSI hitting oversold on weekly chart as shown will be critical along support support 114-110.
If the recovery has to happen then from 78.6%
Chance for entry as long as 100 is not violated comprehensively.
Relatively Under performer.
testing 78.6% retracement looks to be on charts.
114-100 key support levels to stall the fall.
If recovery happen at the support good.
RSI hitting oversold on weekly chart as shown will be critical along support support 114-110.
If the recovery has to happen then from 78.6%
Chance for entry as long as 100 is not violated comprehensively.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。